Clicky

Amylyx Pharmaceuticals, Inc.(AMLX) News

Date Title
Sep 6 Director MILNE GEORGE M JR Acquires 100,000 Shares of Amylyx Pharmaceuticals Inc (AMLX)
Aug 28 Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences
May 10 Amylyx Pharmaceuticals Reports Q1 2024 Financial Results
May 10 Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2024 Earnings Call Transcript
May 9 Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Loss, Lags Revenue Estimates
May 9 Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results
May 8 Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference
May 2 Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
Apr 30 Trials to watch: Four ALS drugs to keep an eye on
Apr 12 The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals
Apr 10 Amylyx Pharmaceuticals' Investigational Drug Shows Improved Pancreatic Function In Patients With Inherited Disorder
Apr 10 Biotech Stock Roundup: MRNA Up on Vaccine Data, BMY's Updates & More News
Apr 10 Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome
Apr 8 Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024
Apr 6 Analysts Just Slashed Their Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) EPS Numbers
Apr 4 Amylyx (AMLX) Withdraws ALS Drug, Cuts Workforce by 70%
Apr 4 ALS drug will be pulled from US market after study showed patients didn't benefit
Apr 4 UPDATE 1-Amylyx Pharma to remove ALS drug from US, Canada markets
Apr 4 Amylyx Is Cutting 70% of Its Workforce and Pulling ALS Drug From the Market
Apr 4 Amylyx Pharmaceuticals Announces Formal Intention to Remove RELYVRIO®/ALBRIOZA™ from the Market; Provides Updates on Access to Therapy, Pipeline, Corporate Restructuring, and Strategy